Cart (0 Items)
Your cart is currently empty.
View ProductsIt looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.
Switch to US ($)
| Size | 100ug, 1MG |
|---|---|
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Product name | Durvalumab Biosimilar - Research Grade mAb |
|---|---|
| Source | DrugBank DB11714 |
| Origin species | Human |
| Expression system | Mammalian |
| Purity | >85% |
| Buffer | PBS pH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery lead time in business days | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | 4°C for short term, -20°C for long term |
| Brand | ProteoGenix |
| Aliases /Synonyms | Durvalumab,Durvalumab,PD-L1,anti-PD-L1 |
| Reference | PX-TA1002-d-100 |
| Note | For research use only. Not suitable for human use. |
| Isotype | IgG1 |
| Clonality | Monoclonal antibody |
Durvalumab Biosimilar - Anti-PD-L1 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Immobilized Human PDL1, B7-H1, CD274 recombinant protein (cat. No.PX-P4038) at 0.5µg/mL (100µL/well) can bind to Durvalumab Biosimilar - Anti-PD-L1 mAb (cat. No.PX-TA1002) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.